HGH Fragment 176-191 5 mg
research-grade
lyophilized peptide powder
in a glass vial. HGH Fragment 176-191 (also known as AOD-9604) is a synthetic C-terminal
fragment of human growth hormone studied in experimental models of lipolysis, adipocyte
metabolism and growth hormone receptor–related signaling.
Research Use Only:
All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
High-purity research grade
Form
Lyophilized peptide powder
Content
5 mg HGH Fragment 176-191 per vial
Packaging
Glass vial with sterile closure
Storage
Store lyophilized at 2–8 °C (desiccated, protect from light)
Molecular formula
C78
H123
N23
O23
S2
Molecular weight
≈ 1815.1 g·mol⁻¹
Sequence
Tyr-Leu-Arg-Asp-Asn-Lys-Phe-His-Gly-Ser-Arg-Pro-Gly-Lys-Lys
In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC).
For a compatible research-only solvent, see
Bacteriostatic water – 10 ml
.
Research Overview
HGH Fragment 176-191 (AOD-9604) corresponds to the C-terminal 16–amino-acid region of human
growth hormone. In experimental models it is used to investigate GH-fragment signaling,
lipolytic pathways in adipocytes and metabolic regulation, while avoiding direct activation
of full-length GH receptor mitogenic pathways. All studies remain strictly within
laboratory/experimental contexts without therapeutic claims.
Primary Research Areas
-
Lipolysis & adipocyte metabolism:
Experimental models assessing hormone-sensitive lipase activation, fatty acid release
and triglyceride turnover in adipose tissue.
-
Growth hormone fragment signaling:
In vitro work on downstream pathways modulated by the 176-191 fragment compared with
full-length GH, including cAMP and MAPK-related cascades.
-
Metabolic & energy-balance research:
Laboratory studies exploring body-composition and energy-expenditure pathways in
controlled animal and cell-based models.
